Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.

scientific article published in May 2004

Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation. is …

instance of (P31):

scholarly article

External links are

PubMed publication ID

P50	author	Hala Gali-Muhtasib	Q51113283
		Ghazi Zaatari	Q114398771
P2093	author name string	Makhluf J Haddadin
		Hala Gali-Muhtasib
		Mazen Sidani
		Fady Geara
		Josianne Al-Hmaira
		Assaf-Diab Mona
P433	issue	5
P921	main subject	angiogenesis inhibitor	Q574834
P304	page(s)	1121-1131
P577	publication date	2004-05-01
P1433	published in	International Journal of Oncology	Q6051527
P1476	title	Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation
P478	volume	24

Reverse relations

cites work (P2860)

Q39631718	Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
Q35633828	MR imaging of therapy-induced changes of bone marrow
Q35589210	Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells
Q38759912	The photoprotective effects of 2-benzoyl-3-phenylquinoxaline 1,4-dioxide against UVB-induced damage in HaCaT cells
Q37599071	The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway
Q37276709	The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells